Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

315 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Quality of life, disease activity and preferences for administration routes in rheumatoid arthritis: a multicentre, prospective, observational study.
Direskeneli H, Karadag O, Ates A, Tufan A, Inanc N, Koca SS, Cetin GY, Akar S, Cinar M, Yilmaz S, Yilmaz N, Dalkilic E, Bes C, Yilmazer B, Sahin A, Ersözlü D, Tezcan ME, Sen N, Keser G, Kalyoncu U, Armagan B, Hacibedel B, Helvacioglu K, Cesur TY, Basibuyuk CS, Alkan S, Gunay LM. Direskeneli H, et al. Among authors: alkan s. Rheumatol Adv Pract. 2022 Sep 2;6(3):rkac071. doi: 10.1093/rap/rkac071. eCollection 2022. Rheumatol Adv Pract. 2022. PMID: 36133962 Free PMC article.
Efficacy and safety of tofacitinib in rheumatoid arthritis-associated interstitial lung disease: TReasure real-life data.
Kalyoncu U, Bilgin E, Erden A, Satış H, Tufan A, Tekgöz E, Ateş A, Coşkun BN, Yağız B, Küçükşahin O, Yazısız V, Kimyon G, Bes C, Başıbüyük CS, Alkan S, Cesur TY, Ertenli İ, Kiraz S. Kalyoncu U, et al. Among authors: alkan s. Clin Exp Rheumatol. 2022 Nov;40(11):2071-2077. doi: 10.55563/clinexprheumatol/9h6dtb. Epub 2022 Jan 25. Clin Exp Rheumatol. 2022. PMID: 35084323 Free article.
Unintentional Monotherapy in Rheumatoid Arthritis Patients Receiving Tofacitinib and Drug Survival Rate of Tofacitinib.
Inanc N, Abacar KY, Ozturk MA, Tufan A, Karadeniz H, Sari I, Can G, Erez Y, Pehlivan Y, Dalkilic HE, Ocak T, Cefle A, Yazici A, Senel AS, Akar S, Durak-Ediboğlu E, Koca SS, Piskin-Sagir R, Yilmaz S, Gulcemal S, Soysal-Gunduz O, Basibuyuk CS, Alkan S, Cesur TY, Onen F. Inanc N, et al. Among authors: alkan s. J Clin Rheumatol. 2023 Dec 1;29(8):365-369. doi: 10.1097/RHU.0000000000002026. Epub 2023 Sep 19. J Clin Rheumatol. 2023. PMID: 37724891 Free PMC article.
B-cell prolymphocytic leukemia: an enduring bona fide entity.
Gonzalez-Mancera MS, Lopategui J, Hoffman D, Kitahara S, Alkan S. Gonzalez-Mancera MS, et al. Among authors: alkan s. Int J Hematol. 2024 May 26. doi: 10.1007/s12185-024-03774-4. Online ahead of print. Int J Hematol. 2024. PMID: 38796826
Investigation of hematologic findings related to brucellosis in Anatolian region.
Çelik M, Arslan Y, Topcu E, Serhat Şahinoğlu M, Altındağ D, Gürbüz E, Atalay E, Kışlak Demircan S, Emre S, Kırık Y, Yürük Atasoy P, Özer D, İpek D, Doğan E, Bilgiç Atlı S, Gülderen Kuşçu E, Alkan S, Çiçek Y, Yüksekkaya E, Aldemir Ö, Şahin A, Yekta Ürkmez F, Özdemir Al S, Boran R, Oğuz Mızrakçı S, Kübra Dindar Demiray E, Reşat Ceylan M, Erdoğdu H, Tekin S. Çelik M, et al. Among authors: alkan s. Saudi Med J. 2024 May;45(5):495-501. doi: 10.15537/smj.2024.45.5.20230847. Saudi Med J. 2024. PMID: 38734423 Free PMC article.
315 results